This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2020 Feb 24;11(1):1095.

doi: 10.1038/s41467-020-14808-w.

Author Correction: MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer

Yota Yasumizu¹, Hasan Rajabi¹, Caining Jin¹, Tsuyoshi Hata^{1

2}, Sean Pitroda³, Mark D Long⁴, Masayuki Hagiwara¹, Wei Li¹, Qiang Hu⁴, Song Liu⁴, Nami Yamashita¹, Atsushi Fushimi¹, Ling Kui¹, Mehmet Samur¹, Masaaki Yamamoto^{1

2}, Yan Zhang¹, Ning Zhang¹, Deli Hong¹, Takahiro Maeda⁵, Takeo Kosaka⁵, Kwok K Wong⁶, Mototsugu Oya⁵, Donald Kufe⁷

Affiliations

Affiliations

¹ Dana-Farber Cancer Institute Harvard Medical School, Boston, MA, USA.
² Department of Gastrointestinal Surgery, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
³ Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, USA.
⁴ Department of Biostatistics and Bioinformatics Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
⁵ Department of Urology, Keio University School of Medicine Shinjuku-ku, Tokyo, Japan.
⁶ Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA.
⁷ Dana-Farber Cancer Institute Harvard Medical School, Boston, MA, USA. donald_kufe@dfci.harvard.edu.

PMID: 32094369
PMCID: PMC7039914
DOI: 10.1038/s41467-020-14808-w

Published Erratum

Author Correction: MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer

Yota Yasumizu et al. Nat Commun. 2020.

. 2020 Feb 24;11(1):1095.

doi: 10.1038/s41467-020-14808-w.

Authors

Yota Yasumizu¹, Hasan Rajabi¹, Caining Jin¹, Tsuyoshi Hata^{1

2}, Sean Pitroda³, Mark D Long⁴, Masayuki Hagiwara¹, Wei Li¹, Qiang Hu⁴, Song Liu⁴, Nami Yamashita¹, Atsushi Fushimi¹, Ling Kui¹, Mehmet Samur¹, Masaaki Yamamoto^{1

2}, Yan Zhang¹, Ning Zhang¹, Deli Hong¹, Takahiro Maeda⁵, Takeo Kosaka⁵, Kwok K Wong⁶, Mototsugu Oya⁵, Donald Kufe⁷

Affiliations

¹ Dana-Farber Cancer Institute Harvard Medical School, Boston, MA, USA.
² Department of Gastrointestinal Surgery, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
³ Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, USA.
⁴ Department of Biostatistics and Bioinformatics Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
⁵ Department of Urology, Keio University School of Medicine Shinjuku-ku, Tokyo, Japan.
⁶ Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA.
⁷ Dana-Farber Cancer Institute Harvard Medical School, Boston, MA, USA. donald_kufe@dfci.harvard.edu.

PMID: 32094369
PMCID: PMC7039914
DOI: 10.1038/s41467-020-14808-w

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

PubMed Disclaimer

Erratum for

MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer.
Yasumizu Y, Rajabi H, Jin C, Hata T, Pitroda S, Long MD, Hagiwara M, Li W, Hu Q, Liu S, Yamashita N, Fushimi A, Kui L, Samur M, Yamamoto M, Zhang Y, Zhang N, Hong D, Maeda T, Kosaka T, Wong KK, Oya M, Kufe D. Yasumizu Y, et al. Nat Commun. 2020 Jan 17;11(1):338. doi: 10.1038/s41467-019-14219-6. Nat Commun. 2020. PMID: 31953400 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal